PAEDIATRIC HAEMORRHAGE AND AIRWAY PROCEDURES
With
Associate Professor Shane George,
Paediatric Emergency physician &
Paediatric intensive care physician,
Gold Coast University Hospital,
Queensland, Australia
RESEARCHER PROFILE
Filmed in Southport, Queensland, Australia | March 2026
Dr Shane George is a paediatric critical care physician working in paediatric emergency medicine and paediatric intensive care at Gold Coast University Hospital. He is the clinical lead for children’s critical care research for Gold Coast Health, and is a Senior Lecturer at The University of Queensland and Griffith University.
Associate Professor George is also an active clinician researcher on topics that span both emergency medicine and PICU practice including safety in emergency intubation, sepsis, haemostatic resuscitation in children and respiratory support therapies.
He is a member of the Paediatric Research in Emergency Departments International collaborative (PREDICT) and the ANZICS Paediatric Study Group, collaborating on numerous multicentre projects.
Associate Professor George’s research has been funded by Australia’s Emergency Medicine Foundation, Australian Government NHMRC and MRFF, the US based Thrasher Research Foundation.
Source: Supplied and Gold Coast Health website
-
Professor Christoph Hagemeyer
RESEARCH IN NANOBIOTECHNOLOGY
@ MONASH UNIVERSITY
VICTORIA, AUSTRALIA -
CASE STUDY Link between levels of extracellular vesicles in the blood and tissue damage caused by diseases
A landmark study led by WEHI and La Trobe University has found a potential new diagnostic marker that could be used to better detect the level of tissue damage in our bodies.
This study revealed, for the first time, a link between levels of EVs in the blood and tissue damage caused by diseases such as leukaemia.
Researchers hope to leverage the critical new insight to develop a blood test to monitor cancer patients with tissue damage, which could, in future, enhance treatment strategies for blood cancers and other diseases.
-
Superslayer taking on antibiotic-resistant bacteria
Dr Katharina Richter is a visionary leader in MedTech, acclaimed for innovation and gender diversity. With over 40 awards to her name, including MIT Innovator Under 35 Asia-Pacific, and Prime Minister’s Prize for New Innovator finalist, she has shattered barriers as an entrepreneur, scientist, and ‘superbug slayer.’ Katharina’s groundbreaking work in combating antibiotic-resistant bacteria has resulted in 6 innovative treatments, 3 of which are patented, offering hope against deadly infections.
